Rouillé Y, Martin S, Steiner D F
Department of Biochemistry and Molecular Biology, University of Chicago, Illinois 60637, USA.
J Biol Chem. 1995 Nov 3;270(44):26488-96. doi: 10.1074/jbc.270.44.26488.
Proglucagon is processed differently in the islet alpha cells and the intestinal endocrine L cells to release either glucagon or glucagon-like peptide 1-(7-37) (GLP1-(7-37)), peptide hormones with opposing actions in vivo. In previous studies with a transformed alpha cell line (alpha TC1-6) we demonstrated that the kexin/subtilisin-like prohormone convertase, PC2 (SPC2), is responsible for generating the typical alpha cell pattern of proglucagon processing, giving rise to glucagon and leaving unprocessed the entire C-terminal half-molecule known as major proglucagon fragment or MPGF (Rouillé, Y., Westermark, G., Martin, S. K., Steiner. D. F. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 3242-3246). Here we present evidence, using mouse pituitary AtT-20 cells infected with a vaccinia viral vector encoding proglucagon, that PC3 (SPC3), the major neuroendocrine prohormone convertase in these cells, reproduces the intestinal L cell processing phenotype, in which MPGF is processed to release two glucagon-related peptides, GLP1 and GLP2, while the glucagon-containing N-terminal half-molecule (glicentin) is only partially processed to oxyntomodulin and small amounts of glucagon. Moreover, in AtT-20 cells stably transfected with PC2 (AtT-20/PC2 cells), glicentin was efficiently processed to glucagon, providing further support for the conclusion that PC2 is the enzyme responsible for the alpha cell processing phenotype. In other cell lines expressing both PC2 and PC3 (STC-1 and beta TC-3), proglucagon was also processed extensively to both glucagon and GLP1-(7-37), although STC-1 cells express lower levels of PC2 and processed the N-terminal domain to glucagon less efficiently. In contrast, GH4C1 and COS 7 cells, which express very little or no PC2 or PC3, failed to process proglucagon, aside from a low level of interdomain cleavage which occurred only in the GH4C1 cells. In vitro PC3 did not cleave at the single Arg residue in GLP1 to generate GLP1-(7-37), its truncated biologically active form, indicating the likelihood that another convertase is required for this cleavage.
胰高血糖素原在胰岛α细胞和肠道内分泌L细胞中的加工方式不同,分别释放胰高血糖素或胰高血糖素样肽1-(7 - 37)(GLP1-(7 - 37)),这两种肽类激素在体内具有相反的作用。在之前对转化的α细胞系(αTC1 - 6)的研究中,我们证明了激肽释放酶/枯草杆菌蛋白酶样激素原转化酶PC2(SPC2)负责产生胰高血糖素原加工的典型α细胞模式,产生胰高血糖素,而未加工整个C端半分子,即所谓的主要胰高血糖素原片段或MPGF(Rouillé, Y., Westermark, G., Martin, S. K., Steiner. D. F. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 3242 - 3246)。在此,我们提供证据表明,利用感染了编码胰高血糖素原的痘苗病毒载体的小鼠垂体AtT - 20细胞,这些细胞中的主要神经内分泌激素原转化酶PC3(SPC3)再现了肠道L细胞加工表型,其中MPGF被加工释放出两种与胰高血糖素相关的肽,GLP1和GLP2,而含胰高血糖素的N端半分子(肠促胰素)仅部分加工为胃泌酸调节素和少量胰高血糖素。此外,在稳定转染了PC2的AtT - 20细胞(AtT - 20/PC2细胞)中,肠促胰素有效地加工为胰高血糖素,这进一步支持了PC2是负责α细胞加工表型的酶的结论。在同时表达PC2和PC3的其他细胞系(STC - 1和βTC - 3)中,胰高血糖素原也广泛加工为胰高血糖素和GLP1-(7 - 37),尽管STC - 1细胞中PC2的表达水平较低,且将N端结构域加工为胰高血糖素的效率较低。相比之下,几乎不表达或不表达PC2或PC3的GH4C1和COS 7细胞,除了仅在GH4C1细胞中发生的低水平结构域间切割外,未能加工胰高血糖素原。体外实验中,PC3不会在GLP1中的单个精氨酸残基处切割以生成其截短的生物活性形式GLP1-(7 - 37),这表明这种切割可能需要另一种转化酶。